Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cellsShahar Lev-Ari, Ludmila Strier, Diana Kazanov, et al.
Stress (Amsterdam, Netherlands)|March 1, 2024
Multi-omics in stress and health research: study designs that will drive the field forwardSummer Mengelkoch, Jeffrey Gassen, Shahar Lev-Ari, et al.
Head & Neck|February 28, 2012
Targeting ErbB-1 and ErbB-4 in irradiated head and neck cancer: results of in vitro and in vivo studiesItay Barnea, Sasha Haif, Rom Keshet, et al.
The Oncologist|June 30, 2011
A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancerNeora Yaal-Hahoshen, Yair Maimon, Nava Siegelmann-Danieli, et al.
The Prostate|April 19, 2007
ErbB-4 may control behavior of prostate cancer cells and serve as a target for molecular therapyRami Ben-Yosef, Alex Starr, Victoria Karaush, et al.
Global Health Promotion|March 29, 2021
Health promotion preparedness for health crises - a 'must' or 'nice to have'? Case studies and global lessons learned from the COVID-19 pandemicDiane Levin-Zamir, Kristine Sorensen, Tin Tin Su, et al.
Integrative Cancer Therapies|July 26, 2018
Modified Citrus Pectin as a Potential Sensitizer for Radiotherapy in Prostate CancerSefora Conti, Akiva Vexler, Lior Hagoel, et al.
Journal of Clinical Medicine|August 29, 2024
Occult Serologically Confirmed Cases of SARS-CoV-2 Coronavirus among the General Population in the Era of the Fourth VaccinationMori Hay Levy, Neta Cohen, Rotem Marom, et al.
International Journal of Cancer|February 8, 2006
ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti-cancer therapyAlex Starr, Joel Greif, Akiva Vexler, et al.
Therapeutic Advances in Gastroenterology|December 25, 2010
Chemopreventive effects of Coltect, a novel dietary supplement, alone and in combination with 5-aminosalicylic acid in 1,2-dimethylhydrazine-induced colon cancer in ratsIlan Aroch, Sarah Kraus, Inna Naumov, et al.
Pageof 7